Gainers
- 60 Degrees SXTP stock rose 85.5% to $1.43 during Wednesday's pre-market session. The company's market cap stands at $3.2 million.
- Silexion Therapeutics SLXN stock increased by 22.22% to $1.65. The market value of their outstanding shares is at $6.5 million.
- Tonix Pharmaceuticals TNXP stock increased by 12.54% to $0.52. The company's market cap stands at $96.7 million.
- MiNK Therapeutics INKT stock rose 12.34% to $6.19. The company's market cap stands at $24.5 million.
- MiMedx Group MDXG shares increased by 10.37% to $10.0. The market value of their outstanding shares is at $1.4 billion.
- Design Therapeutics DSGN stock rose 9.78% to $5.5. The company's market cap stands at $311.4 million.
Losers
- Zentalis Pharma ZNTL shares declined by 27.9% to $1.73 during Wednesday's pre-market session. The company's market cap stands at $123.2 million.
- Eyenovia EYEN shares fell 17.72% to $0.05. The company's market cap stands at $5.2 million.
- IMAC Hldgs BACK shares declined by 16.4% to $1.02. The company's market cap stands at $2.0 million.
- Catheter Precision VTAK stock fell 16.29% to $0.35. The company's market cap stands at $2.8 million.
- Pulmonx LUNG shares fell 15.71% to $5.1. The market value of their outstanding shares is at $201.3 million.
- TransCode Therapeutics RNAZ shares declined by 11.98% to $8.75. The market value of their outstanding shares is at $6.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
DSGNDesign Therapeutics Inc
$4.94-%
EYENEyenovia Inc
$0.03802.15%
INKTMiNK Therapeutics Inc
$6.60-%
LUNGPulmonx Corp
$5.83-%
MDXGMiMedx Group Inc
$9.05-%
RNAZTransCode Therapeutics Inc
$8.37-0.36%
SLXNSilexion Therapeutics Corp
$2.06-34.4%
SXTP60 Degrees Pharmaceuticals Inc
$1.02-3.77%
TNXPTonix Pharmaceuticals Holding Corp
$0.4052-5.77%
VTAKCatheter Precision Inc
$0.4190-0.05%
ZNTLZentalis Pharmaceuticals Inc
$1.88-0.53%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in